Wendy A. Woodward

On mammary stem cells.

Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.

Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.

Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions.

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.

Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype.

Have we made progress in inflammatory breast cancer? Not so fast.

Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype.

Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.

Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.

Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.

Inflammatory breast cancer: what we know and what we need to learn.

Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.

Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.

Genomic and expression analysis of microdissected inflammatory breast cancer.

Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.

Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency.

The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.

Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.

High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.

Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.

Statistical modeling approach to quantitative analysis of interobserver variability in breast contouring.

Current clinical coverage of Radiation Therapy Oncology Group-defined target volumes for postmastectomy radiation therapy.

Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.

Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.

Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?

Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla.

Postmastectomy radiation therapy for inflammatory breast cancer: is more better?

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.

miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.

Circulating tumor cells in newly diagnosed inflammatory breast cancer.

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.

Should Surgery Referral be Standard Practice in Metastatic Inflammatory Breast Cancer?

Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique.

Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.

High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer.

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.

Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment.

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.

Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.

Breast Radiation Therapy--Sometimes Less May Be More.

Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.

Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers.

Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.

Breast Cancer Stem Cell Correlates as Predicative Factors for Radiation Therapy.

Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.

Inflammatory breast cancer: unique biological and therapeutic considerations.

Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Implementing a Real-Time Electronic Data Capture System to Improve Clinical Documentation in Radiation Oncology.

Epidemiological risk factors associated with inflammatory breast cancer subtypes.

MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer.

miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.

Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism.

Steroid Tumor Environment in Male and Female Mice Model of Canine and Human Inflammatory Breast Cancer.

Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation.

Cancer Stem Cells.

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.

Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response.

Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.

Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer.

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Inflammatory breast cancer: a model for investigating cluster-based dissemination.

Novel therapeutic strategies in the treatment of triple-negative breast cancer.

NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.

Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free Survival.

A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.

Effect of statins on breast cancer recurrence and mortality: a review.

Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.

Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.

Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects.

Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference.

Inflammatory breast cancer biology: the tumour microenvironment is key.

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.

Reply to 'A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18'.

Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.

Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key.

Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.

Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer.

Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.

Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.

Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer.

Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.

A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer.

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.

Targeting the Tumor Microenvironment in Radiation Oncology: Proceedings from the 2018 ASTRO-AACR Research Workshop.

Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.

Elevated serum levels of sialyl Lewis X (sLe) and inflammatory mediators in patients with breast cancer.

Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.

The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists.

Building momentum for subsets of patients with advanced triple-negative breast cancer.

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.

Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials.

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.

Molecular Predictive and Prognostic Markers in Locoregional Management.

IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.

In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer.

Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center.

Understanding the Intersection of Working from Home and Burnout to Optimize Post-COVID19 Work Arrangements in Radiation Oncology.

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer.

NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer.

Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer.

Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer.

Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum.